Variant report
Variant | esv2760207 |
---|---|
Chromosome Location | chr11:93692312-93701588 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:93691026..93692794-chr11:93694188..93696052,2 | K562 | blood: | |
2 | chr11:93691026..93692794-chr11:93694188..93696052,2 | K562 | blood: | |
3 | chr11:93700458..93703504-chr11:93704523..93708049,5 | K562 | blood: | |
4 | chr11:93700752..93703504-chr11:93704529..93706599,2 | K562 | blood: | |
5 | chr11:93684701..93687298-chr11:93690286..93693320,3 | K562 | blood: | |
6 | chr11:93699154..93702139-chr11:93715372..93717196,2 | K562 | blood: | |
7 | chr11:93687985..93689849-chr11:93692203..93693783,2 | K562 | blood: | |
8 | chr11:93698163..93699732-chr11:93702050..93703572,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565548388 | chr11:93692339-93692340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2456570 | chr11:93692372-93692373 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs572353670 | chr11:93692400-93692401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187934055 | chr11:93692414-93692415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112894645 | chr11:93692430-93692431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372926427 | chr11:93692432-93692433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7484198 | chr11:93692450-93692451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs576272231 | chr11:93692471-93692472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532996990 | chr11:93692481-93692482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562240598 | chr11:93692482-93692483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191968324 | chr11:93692628-93692629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185479811 | chr11:93692680-93692681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559437814 | chr11:93692689-93692690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189537202 | chr11:93692694-93692695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577652383 | chr11:93692695-93692696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192979203 | chr11:93692720-93692721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111505278 | chr11:93692747-93692748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141335513 | chr11:93692790-93692791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184222635 | chr11:93692803-93692804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143330555 | chr11:93692829-93692830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370364161 | chr11:93692832-93692833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531035492 | chr11:93692843-93692844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549150537 | chr11:93692852-93692853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568187909 | chr11:93692854-93692855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2456571 | chr11:93692858-93692859 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs547373606 | chr11:93692882-93692883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74978748 | chr11:93692896-93692897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566801674 | chr11:93692945-93692946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7934440 | chr11:93692947-93692948 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs549441472 | chr11:93692979-93692980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150836824 | chr11:93693008-93693009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12807496 | chr11:93693064-93693065 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs12362126 | chr11:93693072-93693073 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs74941773 | chr11:93693088-93693089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574079023 | chr11:93693136-93693137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541123964 | chr11:93693137-93693138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553345556 | chr11:93693192-93693193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113009834 | chr11:93693202-93693203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544979670 | chr11:93693251-93693252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557990241 | chr11:93693256-93693257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1105113 | chr11:93693323-93693324 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs531100504 | chr11:93693384-93693385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544789255 | chr11:93693393-93693394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534165387 | chr11:93693394-93693395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138247372 | chr11:93693404-93693405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1105114 | chr11:93693511-93693512 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs565693536 | chr11:93693519-93693520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532986852 | chr11:93693547-93693548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551383732 | chr11:93693590-93693591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570008645 | chr11:93693611-93693612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93692000-93692800 | Enhancers | Pancreas | Pancrea |
2 | chr11:93692200-93692600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr11:93692600-93694600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr11:93692800-93693400 | Weak transcription | Pancreas | Pancrea |
5 | chr11:93693000-93693600 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr11:93693400-93693600 | Enhancers | Pancreas | Pancrea |
7 | chr11:93694400-93696000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr11:93694600-93696400 | Enhancers | HMEC | breast |
9 | chr11:93694600-93696600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr11:93694800-93695200 | Enhancers | Fetal Lung | lung |
11 | chr11:93694800-93695600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr11:93695000-93695400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr11:93695000-93695400 | Enhancers | NHEK | skin |
14 | chr11:93695000-93695600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr11:93695000-93696800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
16 | chr11:93695400-93695600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
17 | chr11:93695400-93696400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr11:93695600-93697000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr11:93695800-93696400 | Enhancers | K562 | blood |
20 | chr11:93696800-93697000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
21 | chr11:93700200-93701400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
22 | chr11:93701400-93701800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |